Absolute benefit from adjuvant chemotherapy in contemporary clinical trials: A systemic review and meta-analysis
Author:
Publisher
Elsevier BV
Subject
Radiology, Nuclear Medicine and imaging,Oncology,General Medicine
Reference37 articles.
1. https://seer.cancer.gov/statfacts/html/breast.html, accessed March 2018.
2. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials;Early Breast Cancer Trialists' Collaborative Group (EBCTCG);Lancet,2012
3. Progress in adjuvant chemotherapy for breast cancer: an overview;Anampa;BMC Med,2015
4. Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer;Berry;JAMA,2006
5. Definitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trial;Swain;J Clin Oncol,2013
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Clinical and Biological Aspects of Disseminated Tumor Cells and Dormancy in Breast Cancer;Frontiers in Cell and Developmental Biology;2022-06-28
2. Sequential versus concurrent adjuvant chemo-endocrine therapy for HR+ early breast cancer: a systematic review and Bayesian network meta-analysis;Translational Breast Cancer Research;2022-01
3. The Impact of Genomic Profiling on Adjuvant Therapy Recommendation in Postmenopausal Women with ER-Positive, T1-2 Breast Cancer: Can Genomic Profiling Eliminate the Need for Sentinel Lymph Node Biopsy?;Clinical Breast Cancer;2021-12
4. Real-world analysis of clinical and economic impact of 21-gene recurrence score (RS) testing in early-stage breast cancer (ESBC) in Ireland;Breast Cancer Research and Treatment;2021-04-09
5. CDK 4/6 inhibitors mired in uncertainty in HR positive and HER2 negative early breast cancer;The Breast;2021-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3